Cargando…

MON-LB46 Thyrotropinoma and Pregnancy

Thyrotropinomas (TSHomas) are rare pituitary tumours, comprising 1-2% of all pituitary adenomas. Thyrotropinomas in pregnancy are exceedingly rare and management of these in pregnancy can be challenging due to the potential for maternal and foetal harm. We report the case of a 35 year old woman who...

Descripción completa

Detalles Bibliográficos
Autores principales:	Namboodiri, Divya, Ng, Hui Yi, Davidson, Andrew, Champion, Bernard, Preda, Veronica Angela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Neuroendocrinology and Pituitary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7209015/ http://dx.doi.org/10.1210/jendso/bvaa046.2029

Ejemplares similares

Thyrotropinoma with silent somatotroph and lactotroph adenoma during pregnancy
por: Wu, Yu-Fang, et al.
Publicado: (2022)

MON-LB48 The Genomic Landscape of Sporadic Thyrotrophinomas
por: shen, Angeline, et al.
Publicado: (2020)

MON-LB52 Evaluation of Arterial Stiffness in Acromegaly Patients
por: alagüney, sevil, et al.
Publicado: (2020)

A Rare Event: Pituitary Apoplexy 6 Weeks After Gamma Knife Radiosurgery for a Non-Functioning Pituitary Macroadenoma
por: Sach, Gabrielle, et al.
Publicado: (2021)

SAT-LB46 Depression as an Atypical Presentation of Cushing’s Disease
por: Pahwa, Dhivya, et al.
Publicado: (2020)

MON-LB081 Pituitary Adenomas: A Pan-genomic Classification
por: NEOU, Mario, et al.
Publicado: (2019)

MON-LB082 Elevated Expression of KISSR Is Associated with Secretory Function of Functioning Gonadotroph Adenomas
por: Wang, Linjie, et al.
Publicado: (2019)

MON-LB072 Primary Partial Empty Sella Presenting with Prepubertal Hypogonadotropic Hypogonadism: A Case Report
por: Matabang, Maria Angela, et al.
Publicado: (2019)

MON-LB59 Radiofrequency Ablation as a Primary Therapy for Benign Functioning Insulinoma
por: Alyusuf, Ebtihal Y, et al.
Publicado: (2020)

MON-LB070 Lymphocytic Infundibulo-Neurohypophysitis Producing Regressive Postpartum Diabetes Insipidus
por: Ghervan, Cristina, et al.
Publicado: (2019)

MON-LB60 Prolactin Response to Metformin in Cabergoline-Resistant Prolactinomas: A Prospective Study
por: Corrêa Portari, Luiz Henrique, et al.
Publicado: (2020)

MON-LB078 Desmopressin Stimulated Salivary Cortisol as a Suplementary Tool in the Diagnosis of Cushing's Syndrome
por: Firme, Ricardo
Publicado: (2019)

ODP356 The Cortisol Conundrum: The Diagnostic Work up for Patients With Suspected Cushing's Disease and Hypercortisolaemia in Australia. Results of a Survey and Clinical Audit
por: Arulanantham, Jonathan, et al.
Publicado: (2022)

MON-LB075 Etiological Spectrum and Change Pattern of Pituitary Stalk Thickness: A Single Center Experience in 321 Patients
por: Zhou, Xiang, et al.
Publicado: (2019)

MON-LB58 The Use of 11C Methionine PET CT In Localization of ACTH Dependent Cushing’s Disease
por: ElEbrashy, Shady Ibrahim, et al.
Publicado: (2020)

MON-LB069 When a Routine Postoperative Internal Medicine Consultation Unearths a Hidden Diagnosis
por: Chengappa, Madhuri, et al.
Publicado: (2019)

MON-LB077 A Large Single Institution Series of Neuroendocrine Recovery and Tumor Recurrence after Pituitary Apoplexy
por: Brown, Teresa, et al.
Publicado: (2019)

MON-LB083 The Dimorphic Effects of Short-Term Dietary Changes on the Central and Circulating IGF1 System in Rats
por: Guerra Cantera, Santiago, et al.
Publicado: (2019)

SUN-LB46 Differences in IGF-I Concentrations Between European and US Populations - Consequences for Reference Intervals
por: Bidlingmaier, Martin, et al.
Publicado: (2020)

MON-LB50 Poor Response to Pre-Surgical Treatment With Somatostatin Receptor Ligands Is Associated With Diabetes Mellitus in Patients With Acromegaly
por: Frara, Stefano, et al.
Publicado: (2020)

MON-LB45 Posterior Hypothalamic Involvement on Pre-Operative Magnetic Resonance Imaging as a Predictor for Hypothalamic Obesity in Craniopharyngiomas
por: Rachmasari, Kharisa N, et al.
Publicado: (2020)

MON-LB51 Stimulation for Bilateral Inferior Petrosal Sinus Sampling May Be Unnecessary for Diagnosis of ACTH Dependent Cushing Syndrome
por: Builes-barrera, Carlos Alfonso, et al.
Publicado: (2020)

MON-LB080 Change of T2-Weighted Intensity of Prolactinoma as a Predictable Value for Relapse of Hyperprolactinemia after Cabergoline Withdrawal
por: Kim, Kyungwon, et al.
Publicado: (2019)

SUN-LB069 Pituitary Apoplexy and Pregnancy: Case Report
por: LOTO, MONICA, et al.
Publicado: (2019)

MON-LB49 Atypical Presentation for a 5.5-cm Macroprolactinoma: Unilateral Visual Loss and Only Partial Hypopituitarism; Asymptomatic Hypogonadism
por: panjawatanan, panadeekarn, et al.
Publicado: (2020)

MON-LB076 Patterns of Secondary Hormonal Deficiency Vary among Different Types of Sellar Masses Despite Similar Tumour Size at Presentation
por: Almistehi, Wael, et al.
Publicado: (2019)

MON-LB074 Ultrasonography May Reliably Assess Muscle Architecture in Patients with Cushing's Syndrome in Remission: Comparison with Gold-Standard Muscle MRI
por: Martel, Luciana, et al.
Publicado: (2019)

MON-LB071 Panhypopituitarism Causing a Life Threatening Prolonged QT Interval Which Can Be Reversible with Treatment of Underlying Endocrine Disorders
por: Sittol, Rani, et al.
Publicado: (2019)

MON-LB073 The Serum Creatinine to Serum Cystatin C Ratio Is a Reliable Surrogate Marker of Sarcopenia in Patients with Cushing's Syndrome in Remission
por: Martel, Luciana, et al.
Publicado: (2019)

MON-283 IGF-1 Levels During Normal Pregnancy
por: Thomas, Guillermo Javier, et al.
Publicado: (2020)

MON-LB57 Impact of Imputation Method and Response Cutoffs on Results From the Phase 3 OPTIMAL Study of Oral Octreotide Capsules in Adult Patients With Acromegaly
por: Samson, Susan Leanne, et al.
Publicado: (2020)

MON-LB56 Metabolic Profile in 107 Patients With Childhood Onset Growth Hormone Deficiency (CO-GHD) at the Time of Transition From Pediatric to Adulthood Endocrine Care
por: Doknic, Mirjana, et al.
Publicado: (2020)

MON-LB47 An International Simulated Use Study (PRESTO) to Evaluate Nurse Preferences Between the Lanreotide Autogel New Syringe and Octreotide Long-Acting Release Syringe
por: Adelman, Daphne T, et al.
Publicado: (2020)

MON-LB53 Prior Injectable Somatostatin Receptor Ligand Dose Does Not Predict Oral Octreotide Response In The Treatment Of Acromegaly: Results From The Phase 3 OPTIMAL Study
por: Nachtigall, Lisa B, et al.
Publicado: (2020)

MON-LB079 A Multicenter, Randomized, Open-Label, Phase IV Study Investigating Management of Pasireotide-Associated Hyperglycemia with Incretin-Based Therapy or Insulin in Patients with Acromegaly or Cushing's Disease (CD)
por: Samson, Susan, et al.
Publicado: (2019)

MON-414 The Case of a Dual-Secreting Pituitary Macroadenoma
por: Malkani, Natasha, et al.
Publicado: (2019)

SUN-LB070 Who Killed the Pituitary?
por: Chittimoju, Sanjita, et al.
Publicado: (2019)

MON-430 To B, or Not to B
por: Pradeep, Pallavi, et al.
Publicado: (2019)

MON-409 Ectopic ACTH Syndrome with a Pituitary Mass
por: Lake, Julia, et al.
Publicado: (2019)

MON-LB55 Biochemical Control of Most Patients Reverting to Injectable Long-Acting Somatostatin Receptor Ligands Is Achieved After One Dose: Results From the Phase 3, Randomized, Double Blind, Placebo-Controlled Optimal Study
por: Fleseriu, Maria, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5vmt4no3ks5d5a8nkun5dk7kl5